New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2014
08:41 EDTMDVNMedivation weakness a buying opportunity, says UBS
UBS said Medivation weakness from the PREVAIL presentation is a buying opportunity and said its Q4 urology survey indicates topline PREVAIL data will drive robust utilization. Shares are Buy rated with a $93 price target.
News For MDVN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 25, 2015
16:21 EDTMDVNMedivation reports Q4 EPS $1.96, consensus $1.34
Subscribe for More Information
15:05 EDTMDVNNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include salesforce.com (CRM), consensus 14c... Avago Technologies (AVGO), consensus $1.94... L Brands (LB), consensus $1.80... Workday (WDAY), consensus (6c)... BioMarin (BMRN), consensus (59c)... Concho Resources (CXO), consensus 84c... Antero Resources (AR), consensus 28c... Medivation (MDVN), consensus $1.34... Transocean (RIG), consensus 77c... Sprouts Farmers Market (SFM), consensus 9c... SINA Corporation (SINA), consensus 18c.
February 23, 2015
06:25 EDTMDVNMedivation removed from Focus List at Citigroup
Subscribe for More Information
06:23 EDTMDVNCiti ups TESARO price target to $79, adds to focus list
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use